Publish in this journal
Journal Information
Vol. 74. Issue 2.
Pages 199 (February 2021)
Share
Share
Download PDF
More article options
Vol. 74. Issue 2.
Pages 199 (February 2021)
Letter to the Editor
Full text access
Main challenges of electrolyte imbalance in older patients with COVID-19 and risk of QT prolongation
Principales desafíos del desequilibrio electrolítico en pacientes geriátricos con COVID-19 y riesgo de prolongación del intervalo QT
Visits
...
Amir Rezazadeha,b, Niayesh Mohebbia,b,
Corresponding author
nmohebbi@sina.tums.ac.ir

Corresponding author:
a Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
b Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran
Related content
Rev Esp Cardiol. 2020;73:569-7610.1016/j.rec.2020.05.001
Clara Bonanad, Sergio García-Blas, Francisco José Tarazona-Santabalbina, Pablo Díez-Villanueva, Ana Ayesta, Juan Sanchis Forés, María Teresa Vidán-Austiz, Francesc Formiga, Albert Ariza-Solé, Manuel Martínez-Sellés
Rev Esp Cardiol. 2021;74:199-20010.1016/j.rec.2020.08.018
Clara Bonanad, Pablo Díez-Villanueva, Sergio García-Blas, Manuel Martínez-Sellés
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
To the Editor,

We read with interest the recent article published by Bonanad et al.1

The topic of this consensus document is valuable and important; however, we encountered ambiguities and questions in one part of the article.

In table 3 of the article, in the description of the adverse cardiovascular effects of drugs investigated for COVID-19 treatment, the authors state that correction of hyperkalemia and hypermagnesemia is vital, while correction of hypokalemia and hypomagnesemia may be particularly imperative since low serum levels of potassium and magnesium enhances the possibility of QT prolongation.2

Hypokalemia, probably by modification of ion potassium channel function, can prolong the QT interval in a manner that results in heterogeneity and dispersion of repolarization. Similarly, hypomagnesemia is a well-established predisposing risk factor for torsade de pointes.3 In addition, potassium deficiency seems to be common in severe coronavirus disease 2019 (COVID-19).4 Several findings indicated that serum potassium should be maintained in the high normal range (4.5-5.0 mmol/L), although more evidence is needed to support this practice.3,5

References
[1]
C. Bonanad, S. García-Blas, F.J. Tarazona-Santabalbina, et al.
Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology.
Rev Esp Cardiol., 73 (2020), pp. 569-576
[2]
E.M. Kallergis, C.A. Goudis, E.N. Simantirakis, G.E. Kochiadakis, P.E. Vardas.
Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review.
ScientificWorldJournal., 2012 (2012), pp. 212178
[3]
B.J. Drew, M.J. Ackerman, M. Funk, et al.
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation endorsed by the American Association of Critical-Care Nurses and the International Society for Computerized Electrocardiology.
J Am Coll Cardiol., 55 (2010), pp. 934-947
[4]
G. Lippi, A.M. South, B.M. Henry.
Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19).
Ann Clin Biochem., 57 (2020), pp. 262-265
[5]
S.H. Thomas, E.R. Behr.
Pharmacological treatment of acquired QT prolongation and torsades de pointes.
Br J Clin Pharmacol., 81 (2016), pp. 420-427
Copyright © 2020. Sociedad Española de Cardiología
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?